Charles River Laboratories International Inc (NYSE:CRL)

116.01
BATS BZX Real-Time Price
As of 3:00pm ET
 -0.55 / -0.47%
Today’s Change
94.15
Today|||52-Week Range
119.05
+5.99%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$5.1B

Company Description

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Contact Information

Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington Massachusetts 01887
P:(781) 222-6000
Investor Relations:
(781) 222-6190

Employees

Shareholders

Mutual fund holders53.26%
Other institutional46.43%
Individual stakeholders4.32%

Top Executives

James C. FosterChairman & Chief Executive Officer
Davide A. MolhoPresident & Chief Operating Officer
David Ross SmithChief Financial Officer & Executive Vice President
Shanna L. Cotti-OsmanskiChief Information Officer
Barbara j. PattersonSenior VP-Regulatory Affairs & Compliance